4D Molecular Therapeutics, Inc. financial data

Symbol
FDMT on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
5858 Horton Street #455, Emeryville, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2.25K % +23.5%
Debt-to-equity 7.04 % -32.4%
Return On Equity -28 % +19.4%
Return On Assets -26.2 % +16.8%
Operating Margin -5.58K % -1070%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 49.8M shares +49.8%
Common Stock, Shares, Outstanding 52M shares +21.6%
Entity Public Float 630M USD +329%
Common Stock, Value, Issued 5K USD +25%
Weighted Average Number of Shares Outstanding, Basic 55.6M shares +31.5%
Weighted Average Number of Shares Outstanding, Diluted 55.6M shares +31.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 3.02M USD -86.3%
Revenue from Contract with Customer, Excluding Assessed Tax 3.02M USD -86.3%
General and Administrative Expense 44.1M USD +28.5%
Operating Income (Loss) -168M USD -60.5%
Nonoperating Income (Expense) 24.9M USD +177%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -143M USD -49.6%
Earnings Per Share, Basic -2.77 USD/shares -1.47%
Earnings Per Share, Diluted -2.77 USD/shares -1.47%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 188M USD -32%
Marketable Securities, Current 314M USD +615%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Assets, Current 511M USD +55.6%
Property, Plant and Equipment, Net 19.9M USD -4.21%
Operating Lease, Right-of-Use Asset 21.8M USD +82.1%
Other Assets, Noncurrent 2.86M USD +320%
Assets 604M USD +67%
Accounts Payable, Current 2.92M USD -38%
Employee-related Liabilities, Current 9.61M USD +54.4%
Accrued Liabilities, Current 21.4M USD +110%
Contract with Customer, Liability, Current 35K USD -73.1%
Liabilities, Current 29.5M USD +62.2%
Contract with Customer, Liability, Noncurrent 1.28M USD +16.8%
Operating Lease, Liability, Noncurrent 19.7M USD +64.1%
Other Liabilities, Noncurrent 196K USD +880%
Liabilities 51.1M USD +61.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax 1.08M USD +102%
Retained Earnings (Accumulated Deficit) -527M USD -37.5%
Stockholders' Equity Attributable to Parent 553M USD +67.6%
Liabilities and Equity 604M USD +67%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -29.1M USD -4.24%
Net Cash Provided by (Used in) Financing Activities 319M USD +2800%
Net Cash Provided by (Used in) Investing Activities -263M USD -710%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 52M shares +21.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 26.5M USD +1.02%
Deferred Tax Assets, Valuation Allowance 118M USD +44.3%
Deferred Tax Assets, Gross 123M USD +41.6%
Operating Lease, Liability 24.8M USD +63.8%
Depreciation 4.8M USD +14.3%
Payments to Acquire Property, Plant, and Equipment 710K USD -29.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -143M USD -52.8%
Lessee, Operating Lease, Liability, to be Paid 34.1M USD +79.7%
Property, Plant and Equipment, Gross 35.4M USD +12%
Operating Lease, Liability, Current 5.09M USD +62.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.6M USD +72.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 5.64M USD +79%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure +38.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 9.28M USD +142%
Lessee, Operating Lease, Liability, to be Paid, Year Three 5.35M USD +70.7%
Deferred Tax Assets, Operating Loss Carryforwards 59.5M USD +26.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 11.9M USD +43.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four 5.51M USD +96.1%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 24.5M USD +35.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%